why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.43
Teva- Pharmaceutical Industries Ltd. ADR [NYSE: TEVA] gained 10136607% or 12249983.05 points to close at $12250000.0 with a heavy trading volume of 10136607 shares. It opened the trading session at $17.0, the shares rose to $17.02 and dropped to $16.655, the range by which the